Pharmaceuticals

  1. 19 Sep 2018  |  North America

    Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

    Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

    The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

    $4,950.00
  2. 24 Apr 2018  |  North America

    Growth Insights—Real World Evidence Analytics Solutions Market

    Innovation and Changing End-user Needs Driving Market Growth

    Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...

    $3,000.00
  3. 12 Apr 2018  |  Europe

    Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action

    Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth

    The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

    $3,000.00
  4. 20 Nov 2017  |  North America

    Global Biologics Market—Companies-to-Action

    Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

    This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

    $3,000.00
  5. 16 Aug 2016  |  North America

    Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

    Emerging Business Models Drive Transformation

    The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to c...

    $7,000.00
  6. 04 May 2016  |  Europe

    European Autoimmune Diagnostics Market, Forecast to 2020

    Ageing Population and High Disease Prevalence to Trigger Growth, Localised Disease Segment Offers Revenue Potential

    The high prevalence of diseases in Europe is a market opportunities for the market participants, especially considering the ageing population in these regions. This leads to the need for better and early diagnosis. This market includes revenues from instruments and reagents. Market revenues and installed base (units) for the entire Western Europe, ...

    $1,500.00